Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE44.2900
- TODAY'S CHANGE (%)-0.4200 (-0.9394%)
- Bid / Lots43.0000/ 1
- Ask / Lots45.1500/ 1
- Open / Previous Close44.6500 / 44.7100
- Day Range
- 52 Week Range
- Volume651,679
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 2619 | 44.495 |
| 09:34 ET | 1743 | 43.8551 |
| 09:36 ET | 5810 | 44.65 |
| 09:38 ET | 500 | 44.38 |
| 09:39 ET | 100 | 44.38 |
| 09:41 ET | 200 | 44.5 |
| 09:43 ET | 11042 | 44.9 |
| 09:48 ET | 1160 | 44.8 |
| 09:50 ET | 800 | 44.71 |
| 09:52 ET | 400 | 44.54 |
| 09:54 ET | 100 | 44.305 |
| 09:56 ET | 1160 | 44.56 |
| 09:57 ET | 100 | 44.48 |
| 09:59 ET | 400 | 44.38 |
| 10:01 ET | 4135 | 44.205 |
| 10:03 ET | 8313 | 44.2 |
| 10:06 ET | 922 | 44.36 |
| 10:08 ET | 1659 | 44.325 |
| 10:10 ET | 24100 | 44.25 |
| 10:12 ET | 18051 | 44.245 |
| 10:14 ET | 2721 | 44.28 |
| 10:17 ET | 2715 | 44.23 |
| 10:19 ET | 756 | 44.3 |
| 10:21 ET | 816 | 44.18 |
| 10:24 ET | 1211 | 44.26 |
| 10:26 ET | 100 | 44.21 |
| 10:28 ET | 237 | 44.25 |
| 10:30 ET | 1200 | 44.14 |
| 10:32 ET | 1058 | 44.23 |
| 10:33 ET | 310 | 44.25 |
| 10:35 ET | 100 | 44.19 |
| 10:37 ET | 1400 | 44.1 |
| 10:39 ET | 200 | 44.0601 |
| 10:42 ET | 209 | 44.105 |
| 10:44 ET | 1603 | 44.09 |
| 10:46 ET | 463 | 44.09 |
| 10:48 ET | 100 | 44.09 |
| 10:50 ET | 831 | 44.04 |
| 10:51 ET | 600 | 44.02 |
| 10:53 ET | 1780 | 44.05 |
| 10:55 ET | 1593 | 44.075 |
| 10:57 ET | 1900 | 44.015 |
| 11:00 ET | 2107 | 44.095 |
| 11:02 ET | 1052 | 44.12 |
| 11:04 ET | 700 | 44.145 |
| 11:06 ET | 100 | 44.155 |
| 11:08 ET | 300 | 44.16 |
| 11:09 ET | 600 | 44.135 |
| 11:11 ET | 456 | 44.1 |
| 11:13 ET | 1200 | 44.12 |
| 11:15 ET | 771 | 44.1375 |
| 11:18 ET | 200 | 44.145 |
| 11:20 ET | 2789 | 44.23 |
| 11:22 ET | 200 | 44.235 |
| 11:24 ET | 800 | 44.26 |
| 11:26 ET | 723 | 44.385 |
| 11:29 ET | 1384 | 44.33 |
| 11:31 ET | 400 | 44.28 |
| 11:33 ET | 647 | 44.38 |
| 11:36 ET | 1456 | 44.25 |
| 11:38 ET | 200 | 44.23 |
| 11:40 ET | 700 | 44.255 |
| 11:42 ET | 625 | 44.33 |
| 11:44 ET | 400 | 44.315 |
| 11:45 ET | 779 | 44.29 |
| 11:47 ET | 725 | 44.28 |
| 11:49 ET | 893 | 44.24 |
| 11:51 ET | 195 | 44.22 |
| 11:54 ET | 485 | 44.2 |
| 11:56 ET | 200 | 44.18 |
| 11:58 ET | 1525 | 44.26 |
| 12:00 ET | 200 | 44.25 |
| 12:02 ET | 500 | 44.27 |
| 12:03 ET | 3108 | 44.39 |
| 12:07 ET | 1530 | 44.5 |
| 12:09 ET | 200 | 44.5 |
| 12:12 ET | 200 | 44.485 |
| 12:14 ET | 1696 | 44.5 |
| 12:16 ET | 200 | 44.51 |
| 12:18 ET | 200 | 44.51 |
| 12:20 ET | 1100 | 44.39 |
| 12:21 ET | 1317 | 44.42 |
| 12:23 ET | 848 | 44.44 |
| 12:25 ET | 700 | 44.49 |
| 12:27 ET | 600 | 44.48 |
| 12:30 ET | 1843 | 44.48 |
| 12:32 ET | 820 | 44.34 |
| 12:34 ET | 300 | 44.32 |
| 12:36 ET | 849 | 44.36 |
| 12:38 ET | 200 | 44.365 |
| 12:39 ET | 1035 | 44.36 |
| 12:41 ET | 400 | 44.36 |
| 12:43 ET | 5682 | 44.38 |
| 12:45 ET | 235 | 44.39 |
| 12:48 ET | 700 | 44.35 |
| 12:50 ET | 400 | 44.33 |
| 12:54 ET | 500 | 44.35 |
| 12:56 ET | 425 | 44.38 |
| 12:57 ET | 300 | 44.4 |
| 12:59 ET | 900 | 44.43 |
| 01:01 ET | 438 | 44.415 |
| 01:03 ET | 400 | 44.48 |
| 01:06 ET | 700 | 44.445 |
| 01:08 ET | 1900 | 44.43 |
| 01:10 ET | 200 | 44.43 |
| 01:12 ET | 129 | 44.445 |
| 01:14 ET | 1200 | 44.37 |
| 01:15 ET | 1399 | 44.4 |
| 01:17 ET | 2110 | 44.305 |
| 01:19 ET | 416 | 44.31 |
| 01:21 ET | 100 | 44.315 |
| 01:24 ET | 100 | 44.315 |
| 01:26 ET | 1295 | 44.25 |
| 01:28 ET | 658 | 44.19 |
| 01:30 ET | 236 | 44.215 |
| 01:32 ET | 300 | 44.19 |
| 01:33 ET | 1278 | 44.235 |
| 01:35 ET | 971 | 44.31 |
| 01:37 ET | 8000 | 44.31 |
| 01:39 ET | 6278 | 44.33 |
| 01:42 ET | 306 | 44.32 |
| 01:44 ET | 1657 | 44.41 |
| 01:46 ET | 100 | 44.42 |
| 01:48 ET | 200 | 44.425 |
| 01:50 ET | 400 | 44.425 |
| 01:51 ET | 1372 | 44.4 |
| 01:53 ET | 983 | 44.36 |
| 01:55 ET | 100 | 44.34 |
| 01:57 ET | 131 | 44.355 |
| 02:00 ET | 200 | 44.31 |
| 02:02 ET | 2014 | 44.24 |
| 02:04 ET | 1950 | 44.18 |
| 02:08 ET | 700 | 44.225 |
| 02:09 ET | 100 | 44.23 |
| 02:11 ET | 100 | 44.23 |
| 02:13 ET | 533 | 44.28 |
| 02:15 ET | 229 | 44.26 |
| 02:18 ET | 1102 | 44.23 |
| 02:20 ET | 100 | 44.24 |
| 02:22 ET | 300 | 44.22 |
| 02:24 ET | 200 | 44.2 |
| 02:26 ET | 838 | 44.2 |
| 02:27 ET | 464 | 44.22 |
| 02:29 ET | 1000 | 44.29 |
| 02:31 ET | 124 | 44.32 |
| 02:33 ET | 912 | 44.3 |
| 02:36 ET | 100 | 44.28 |
| 02:38 ET | 2100 | 44.25 |
| 02:40 ET | 317 | 44.25 |
| 02:42 ET | 200 | 44.265 |
| 02:44 ET | 1215 | 44.27 |
| 02:45 ET | 641 | 44.24 |
| 02:47 ET | 324 | 44.265 |
| 02:51 ET | 100 | 44.25 |
| 02:54 ET | 829 | 44.29 |
| 02:56 ET | 103 | 44.34 |
| 02:58 ET | 1508 | 44.3 |
| 03:00 ET | 811 | 44.41 |
| 03:02 ET | 500 | 44.32 |
| 03:03 ET | 800 | 44.21 |
| 03:05 ET | 3565 | 44.27 |
| 03:07 ET | 400 | 44.305 |
| 03:09 ET | 100 | 44.32 |
| 03:12 ET | 634 | 44.26 |
| 03:14 ET | 1400 | 44.315 |
| 03:16 ET | 100 | 44.3 |
| 03:18 ET | 1400 | 44.36 |
| 03:20 ET | 3397 | 44.37 |
| 03:21 ET | 100 | 44.365 |
| 03:23 ET | 200 | 44.38 |
| 03:25 ET | 601 | 44.41 |
| 03:27 ET | 900 | 44.455 |
| 03:30 ET | 1594 | 44.41 |
| 03:32 ET | 931 | 44.39 |
| 03:34 ET | 2052 | 44.5 |
| 03:36 ET | 1800 | 44.545 |
| 03:38 ET | 1200 | 44.565 |
| 03:39 ET | 2941 | 44.46 |
| 03:41 ET | 2112 | 44.51 |
| 03:43 ET | 2991 | 44.51 |
| 03:45 ET | 7247 | 44.49 |
| 03:48 ET | 647 | 44.41 |
| 03:50 ET | 1915 | 44.385 |
| 03:52 ET | 1452 | 44.42 |
| 03:54 ET | 12524 | 44.34 |
| 03:56 ET | 2738 | 44.25 |
| 03:57 ET | 6043 | 44.34 |
| 03:59 ET | 7177 | 44.29 |
Today
Jun 10, 2024
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 6:35PM ET on Monday Jun 10, 2024 by Dow Jones
6:35PM ET on Monday Jun 10, 2024 by Dow Jones
Jun 4, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $80.00/Share by JMP Securities, from 8:29AM ET on Tuesday Jun 04, 2024 by Dow Jones
8:29AM ET on Tuesday Jun 04, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 8:19AM ET on Tuesday Jun 04, 2024 by Dow Jones
8:19AM ET on Tuesday Jun 04, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 7:37AM ET on Tuesday Jun 04, 2024 by Dow Jones
7:37AM ET on Tuesday Jun 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.5B | -11.7x | --- |
Dyne Therapeutics Inc | 3.2B | -8.4x | --- |
Immunovant Inc | 3.9B | -13.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Merus NV | 3.8B | -19.9x | --- |
Immunitybio Inc | 4.0B | -5.9x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.5B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.68 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -11.7x |
Price/Sales (TTM) | 1,786.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
